Targeting Bacterial Biofilms Using Probiotics and Medicinal Plant (Dandelion) Extract: A Comparative Study
DOI:
https://doi.org/10.17140/PHOJ-5-145Keywords:
Bacteria; Biofilms; Extract; Public health; Quorum sensing.Abstract
IntroductionBiofilms are a significant threat to public health as they form on medical devices, wastewater pipes, human tissue, and stagnant water bodies. The primary reason biofilms are hard to combat is the bacterial interactions that take place within the biofilm through quorum sensing (QS), a form of cell-to-cell communication that plays a crucial role in the formation of biofilms. The QS controls biofilm formation to increase cooperation and stabilize the biofilm and increased interactions between the bacterial cells, make the biofilms harder to destroy. The aggregates of cells in the biofilm are not susceptible to drugs. The slow dividing cells are less susceptible to antibiotics.ObjectivesThe aim of this comparative study is to research the potential and effectiveness of treatments to combat the growth of biofilm formed by Escherichia coli and Enterobacter aerogenes by using two approaches: medicinal plant extract of Taraxacum officinale and probiotics.MethodologyThis was a comparative study in which bacterial biofilms of E. coli and E. aerogenes were grown. Each biofilm was treated with a probiotic solution or Taraxacum officinale (dandelion) extract. The effectiveness of each treatment was measured through zones of isolation.ResultsA standard t-test was run to compare the results of two groups of means for each bacteria. For E. aerogenes, the probiotic solution was more effective than dandelion extract with a t-value of 5.5 and a p-value of 0.0003, which is less than a p-value of 0.05. For E. coli, the probiotic solution was more effective than dandelion extract with a t-value of 6.5, and the p-value is less than 0.05. Results show that the probiotics treatment was more effective in destroying the biofilms than the Taraxacum officinale extract, but both treatments showed effective bactericidal properties.ConclusionData from the trials were compared to traditional antibiotics for each of the bacteria, E. coli and E. aerogenes. These two methods of destruction are possible solutions to the threat the biofilms pose. If these research methods prove to be effective, they will be instrumental in combating the biofilms that lead to complications. These are promising solutions for reverting the threat that biofilms pose to public health and ecosystems.
References
Bjarnsholt T. The role of bacterial biofilms in chronic infections. Journal of Pathology, Microbiology and Immunology. 2013; 121: 1-58. doi: 10.1111/apm.12099
Høiby N, Ciofu O, Johansen HK, Song Z-J, Moser C, Jensen PØ, et al. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011; 3(2): 55-65. doi: 10.4248/IJOS11026
Schiebel J, Böhm A, Nitschke J, Burdukiewicz M, Weinreich J, Ali A, et al. Genotypic and phenotypic characteristics associated with biofilm formation by human clinical escherichia coli isolates of different pathotypes. Applied and Environmental Microbiology. 2017; 83 (24): e01660-17. doi: 10.1128/AEM.01660-17
Lau D, Plotkin B. Antimicrobial and biofilm effects of herbs used in traditional chinese medicine. Nat Prod Commun. 2013; 8: 1617-1620.
National Center for Complementary and Integrative Health, U.S. Department of Health and Human Services. nccih Web site. www. nccih.nih.gov/health/dandelion. Accessed April 23, 2020.
Kenny O, Brunton NP, Walsh D, Hewage CM, McLoughlin P, Smyth TJ. Characterisation of antimicrobial extracts from dandelion root (Taraxacum Officinale) using LC-SPE-NMR. Phytother Res. 2015; 29(4): 526-532. doi: 10.1002/ptr.5276
Díaz K, Espinoza L, Madrid A, Pizarro L, Chamy R. Isolation and identification of compounds from bioactive extracts of taraxacum officinale weber Ex F. H. Wigg. (Dandelion) as a potential source of antibacterial agents. Evid Based Complement Alternat Med. 2018; 2018: 2706417. doi: 10.1155/2018/2706417
Moal VL-L, Servin AL. Anti-infective activities of lactobacillus strains in the human intestinal microbiota: From probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clinical Microbiology Reviews. 2014; 27(2): 167-199. doi: 10.1128/CMR.00080-
Beloin C, Roux A, Ghigo J-M. Escherichia coli biofilms. Current topics in Microbiology and Immunology. 2008; 322: 249-289. doi:
1007/978-3-540-75418-3_12 10. Biology LibreTextsTM. 9: Kirby-Bauer (Antibiotic Sensitivity). bio.libretexts Web site. https://bio.libretexts.org/Bookshelves/ Ancillary_Materials/Laboratory_Experiments/Microbiology_ Labs/Microbiology_Labs_I/09%3A_Kirby-Bauer_(Antibiotic_ Sensitivity). Accessed June 3, 2019.
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Public Health - Open Journal (PHOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.